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he steroid hormone ecdysone regulates moulting, cell
death, and differentiation during insect development.
Ecdysone mediates its biological effects by either direct
activation of gene transcription after binding to its receptor
EcR–Usp or via hierarchical transcriptional regulation of
several primary transcription factors. In turn, these tran-
scription factors regulate the expression of several downstream
genes responsible for speciﬁc biological outcomes. DRONC,
the 
 
Drosophila
 
 initiator caspase, is transcriptionally regulated
by ecdysone during development. We demonstrate here
T
 
that the 
 
dronc
 
 promoter directly binds EcR–Usp. We further
show that mutation of the EcR–Usp binding element
(EcRBE) reduces transcription of a reporter and abolishes
transactivation by an EcR isoform. We demonstrate that EcRBE
is required for temporal regulation of 
 
dronc
 
 expression in
response to ecdysone in speciﬁc tissues. We also uncover
the participation of a putative repressor whose function
appears to be coupled with EcR–Usp. These results indicate
that direct binding of EcR–Usp is crucial for controlling the
timing of 
 
dronc
 
 expression in speciﬁc tissues.
 
Introduction
 
Programmed cell death (PCD) is an essential biological process
required for the sculpturing of various tissues and removal of
unwanted cells during development. PCD is mainly executed
by the process of apoptosis and involves a highly conserved
machinery (for review see Baehrecke, 2002; Adams, 2003).
Various signals such as cytotoxic insults, hormones, and
growth factors regulate the activation of PCD by controlling
the balance between pro- and anti-death factors of the cell death
machinery (Baehrecke, 2002; Adams, 2003). Although the
composition of the cell death effector machinery is now
largely understood, how the upstream signals communicate
with the core components of the machinery remains poorly
defined. Many recent studies suggest that transcription plays
a key role in the control of the cell death machinery by
regulating the intracellular levels of the pro- and anti-death
factors (for review see Kumar and Cakouros, 2004).
In 
 
Drosophila melanogaster
 
 a single steroid hormone 20-
hydroxyecdysone (ecdysone) regulates PCD to remove obso-
lete larval tissues (for review see Riddiford, 1993; Thum-
mel, 1996; Baehrecke, 2000, 2002; Truman and Riddiford,
2002). Pulses of ecdysone are produced at various times
during fly development and regulate cell proliferation, differ-
entiation, and death in a temporally and spatially controlled
manner. An ecdysone pulse toward the end of the larval stage
signals puparium formation and histolysis of the larval mid-
gut. A second pulse 
 
 
 
12 h later initiates head eversion and
histolysis of the larval salivary glands. These events are followed
by progenitor cells giving rise to adult tissues (Thummel,
1996; Baehrecke, 2000, 2002; Truman and Riddiford, 2002).
Ecdysone binds to its heterodimeric receptor, EcR–Usp
(ecdysone receptor–ultraspiracle), and transcriptionally regu-
lates several primary response genes. There are three EcR
isoforms in 
 
Drosophila
 
, EcR-A, B1, and B2 (Yao et al., 1993).
These isoforms are highly homologous in the DNA and
ligand binding domains but differ in their amino terminal
transactivation domain. The EcR-B1 isoform is predomi-
nantly expressed in tissues destined to undergo PCD, whereas
the EcR-A isoform is expressed in tissues that differentiate in
response to ecdysone (Talbot et al., 1993; Yao et al., 1993).
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In the larval salivary glands and midgut, ecdysone controls
the expression of several transcription factors, which in turn
regulate several secondary response genes (Jiang et al., 1997;
Baehrecke, 2000, 2002). EcR–Usp and ecdysone-induced
transcription factors 
 
 
 
FTZ-F1, BR-C, E74, E75, and E93
have been shown to play a role in ecdysone-mediated cell
death in larval salivary gland and midgut. For example,
EcR–Usp directly regulates 
 
rpr
 
 transcription in salivary
glands and BR-C is required for maximal 
 
rpr
 
 and 
 
dronc
 
 ex-
pression (Jiang et al., 2000, Cakouros et al., 2002). BR-C
and E74A are also required for the optimal induction of 
 
hid
 
in salivary glands (Jiang et al., 2000). In salivary glands of
the 
 
E93
 
 mutants 
 
rpr
 
, 
 
hid
 
, 
 
ark
 
, and 
 
dronc
 
 mRNA levels are
severely reduced (Lee et al., 2000). These results suggest that
ecdysone-mediated up-regulation of death initiators such as
 
rpr
 
, 
 
hid
 
, 
 
dark
 
, and 
 
dronc
 
 is crucial for PCD in salivary glands
and midgut during 
 
Drosophila
 
 metamorphosis.
Of the seven caspases in 
 
Drosophila,
 
 DRONC is the
CED3/caspase-9-like apical caspase (Dorstyn et al., 1999a;
for review see Kumar and Doumanis, 2000; Richardson and
Kumar, 2002). DRONC is the only fly caspase containing a
caspase recruitment domain, and its function is essential for
PCD in 
 
Drosophila
 
 (Hawkins et al., 2000; Meier et al., 2000;
Quinn et al., 2000; Dorstyn et al., 2002). Interestingly, 
 
dronc
 
is transcriptionally regulated by ecdysone in salivary glands
and midgut during larval-pupal metamorphosis, and 
 
dronc
 
overexpression is sufficient to mediate ecdysone-induced
PCD (Dorstyn et al., 1999a,b; Cakouros et al., 2002). These
studies underscore the importance of direct regulation of cas-
pase levels in initiating PCD in vivo. Furthermore, they pro-
vide evidence that developmental PCD is controlled at the
level of transcription, rather than activation, of a preexisting
cell death machinery alone. Given this evidence, it is essential
to understand the transcriptional control of the caspase acti-
vation machinery. As ecdysone-mediated 
 
dronc
 
 regulation in
 
Drosophila
 
 provides a convenient model to study transcrip-
tional regulation of the core PCD machinery we have been
dissecting out the 
 
dronc
 
 promoter for important transcrip-
tional regulatory elements. Previous work has shown that
BR-C and E93 are important for 
 
dronc
 
 expression by ecdy-
sone (Lee et al., 2000; Cakouros et al., 2002). Preliminary
promoter deletion studies suggest that 
 
dronc
 
 transcriptional
regulation is complex and involves both temporal and spatial
control (Daish et al., 2003). In the present paper, we demon-
strate that EcR-B1 directly binds and transactivates the 
 
dronc
 
promoter and that this binding is necessary for the correct
timing of expression of 
 
dronc
 
 in specific tissues. These studies
provide a basis for investigating both temporal and spatial
regulation of gene transcription of a caspase during develop-
ment by a steroid hormone receptor.
 
Results
 
A specific region of the 
 
dronc
 
 promoter is essential 
for ecdysone-mediated transcription
 
In an effort to identify regions of the 
 
dronc
 
 promoter that are
essential for ecdysone-mediated transcription, a series of dele-
tion constructs containing 2.8, 1.1, and 0.54 kb of the 
 
dronc
 
promoter, cloned in front of the luciferase reporter gene, were
generated and analyzed for their ability to drive reporter ex-
pression by ecdysone. The 
 
Drosophila
 
 cell line 
 
l(2)mbn
 
, which
undergoes ecdysone-induced and 
 
dronc
 
-dependent cell death,
was used in this paper (Ress et al., 2000; Cakouros et al.,
2002). Transient transfections with the reporter constructs
showed that the 2.8-kb promoter was highly responsive to
ecdysone, whereas 1.1 or 0.54 kb promoters were unable to
drive reporter expression after ecdysone treatment (Fig. 1 A).
These experiments also revealed that deletion of the 2.8-kb
Figure 1. Upstream dronc promoter is responsive to ecdysone and 
TSA. (A) 2.5   10
6 l(2)mbn cells were transfected in triplicate with 
2  g of dronc luciferase reporter, pxpDR2.8kbLuc, pxpDR1.1kbLuc, 
or pxpDR0.54kbLuc. After 24 h, cells were treated with 10  M ecdy-
sone (Ecd) for 24 h where indicated ( ). Cell extracts were prepared 
and assayed in triplicate for luciferase activity. Background luciferase 
activity obtained from empty luciferase vector transfections was sub-
tracted from values shown. Error bars represent SD. (B) Experiment 
was conducted as in A except trichostatin A (TSA) was used at 1  M 
where indicated ( ). (C) l(2)mbn cells were treated with ethanol for 
16 h ( ) or with TSA (1  M) for the indicated time. All cells were 
harvested at the same time. 10
7 cells were used for immunoblotting 
using a DRONC antibody. Full-length precursor (Pre) and processed 
(Proc) DRONC species are indicated. For Northern blot analysis, 15 
 g of total RNA was electrophoresed, transferred onto nitrocellulose 
membrane, and probed with dronc probe or a control rp49 probe. 
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promoter to 1.1 kb resulted in a dramatic increase in basal
promoter activity, suggesting the possible recruitment of a re-
pressor to this region (Fig. 1 A). Given that most repressors re-
cruit histone deacetylases to repress transcription, we used the
 
dronc
 
 promoter-reporter constructs in transient transfections
to determine if they were responsive to the histone deacetylase
inhibitor Trichostatin A (TSA). TSA treatment of 
 
l(2)mbn
 
cells transfected with the 
 
dronc
 
-reporter constructs revealed
that the 2.8-kb promoter was activated by TSA, whereas 1.1
and 0.54 kb promoters had lost the ability to respond to TSA
(Fig. 1 B). To further test that 
 
dronc
 
 repression can be allevi-
ated by TSA, we analyzed the endogenous 
 
dronc
 
 transcript
and protein levels (Fig. 1 C). In 
 
l(2)mbn
 
 cells treated with
TSA for 0–16 h, endogenous DRONC precursor increased at
4 h, and then quickly stabilized as it was processed to its active
form (Fig. 1 C). It should be noted that TSA treatment of
 
l(2)mbn
 
 cells for 16 h results in some apoptosis. Northern blot
analysis showed that TSA treatment increased the levels of
 
dronc
 
 up to 8 h, which then stabilized (Fig. 1 C). These data
suggest that alleviation of repression is required for 
 
dronc
 
 ex-
pression. Overall, these experiments demonstrate that the re-
gion between 2.8 and 1.1 kb of the 
 
dronc
 
 promoter is essential
for ecdysone-induced 
 
dronc
 
 transcription and that this region
also harbors a putative repressor element, which presumably
acts by recruiting a histone deacetylase.
 
Cycloheximide partially inhibits 
 
dronc
 
 transcription
 
Although 
 
dronc
 
 has been shown to be regulated by the
ecdysone-induced transcription factors BR-C and E93 (Lee
et al., 2000; Cakouros et al., 2002), two observations suggest
the possibility of EcR–Usp directly binding and activating
the 
 
dronc
 
 upstream promoter. First, previous work has
shown that ecdysone can regulate 
 
dronc
 
 transcription in
 
l(2)mbn
 
 very early (
 
 
 
2 h), whereas other transcription fac-
tors such as BR-C bind to the promoter after 6 h of ecdy-
sone exposure (Cakouros et al., 2002). Second, the upstream
promoter region seems to harbor sites for both repressors
and activators (Daish et al., 2003). Nuclear hormone recep-
tors tend to recruit corepressors in the absence of ligand to
repress transcription and coactivators in the presence of
ligand to activate transcription (Kumar and Thompson,
2003). To examine this possibility, 
 
l(2)mbn
 
 cells were
treated with ecdysone for various times in the presence or
absence of the protein translation inhibitor cycloheximide.
If ecdysone-induced transcription factors are solely respon-
sible for 
 
dronc
 
 transcription, then cycloheximide should
inhibit the ecdysone-mediated 
 
dronc
 
 increase. RT-PCR anal-
ysis showed that 
 
dronc
 
 transcript levels increased with ec-
dysone treatment from 0–12 h (Fig. 2 A). In the presence
of cycloheximide, 
 
dronc
 
 levels at 0 and 6 h were unaffected
but were reduced at 12 h (Fig. 2 A). These results were con-
firmed by Northern blotting (Fig. 2 B) using earlier time
points to demonstrate the early onset of 
 
dronc
 
 transcription,
which is insensitive to cycloheximide treatment. Under
these conditions, the control 
 
rp49
 
 levels were not signifi-
cantly affected. These data support the possibility that the
 
dronc
 
 promoter is directly activated by the preexisting
ecdysone receptor, which acts in tandem with other ecdy-
sone responsive transcription factors to activate 
 
dronc
 
transcription.
 
dronc
 
 promoter contains an EcR–Usp binding 
element (EcRBE)
 
To screen for possible binding of EcR–Usp to the 
 
dronc
 
 pro-
moter, we performed electrophoretic mobility shift analysis
(EMSA) and competition experiments. EMSA experiments
were performed using the 
 
hsp70
 
 EcRBE as a probe and in
vitro translated EcR–Usp proteins (Fig. 3 A). The EcR–Usp
complex was completely abolished when competed with the
cold 
 
hsp
 
EcRBE oligonucleotide, illustrating the specificity of
the complex. 400 bp PCR products spanning the upstream
 
dronc
 
 promoter region were used as competitors in an at-
tempt to locate the EcRBE. Competitors spanning the re-
gion between 2.8 to 1.42 kb had no significant effect on the
EcR–Usp complex, however the region between 1.42–1.0
kb clearly competed out most of the EcR–Usp complex (Fig.
3 A). Further experiments mapped the potential EcRBE to
the region between 1.42 to 1.2 kb (Fig. 3 B). The 
 
 
 
200-bp
region was analyzed in more detail using 60 bp overlapping
oligonucleotides spanning the region. As shown in Fig. 3 C,
only oligonucleotide 2 successfully competed out the EcR–
Usp complex in EMSA, suggesting that the potential EcRBE
in the 
 
dronc
 
 promoter resides within this sequence.
 
An EcR–Usp binding site in the 
 
dronc
 
 promoter
 
Analysis of the 60 bp region revealed a potential EcR–Usp
binding site that has a 10 out of 13 bp match to the consen-
sus EcRBE (Fig. 4 A). An oligonucleotide containing this
potential EcRBE was used as a competitor as well as a mu-
tant oligonucleotide that had specific mutations in the bind-
ing site (Fig. 4 A). As shown in Fig. 4 B, the EcR–Usp com-
plex with the 
 
hsp
 
EcRBE could be competed out with the
 
hsp
 
EcRBE. Increasing amounts of the 
 
dronc
 
EcRBE oligonu-
cleotide also competed the EcR–Usp complex, however
higher amounts were needed to abolish binding of EcR–Usp
Figure 2. Ecdysone-mediated dronc transcription is partially 
cycloheximide sensitive. (A) 10
7 l(2)mbn cells were treated with 
10  M ecdysone (Ecd) for the indicated time in the presence or 
absence (Control) of 10  g/ml cycloheximide (CHX). RNA extracted 
from cells was analyzed by RT-PCR. (B) Northern blot analysis was 
performed on RNA samples from cells treated as in A. Where indicated, 
cells were treated with cycloheximide (CHX) for 2 h.634 The Journal of Cell Biology | Volume 165, Number 5, 2004
to hspEcRBE. The mutant oligonucleotide failed to compete
for the EcRBE (Fig. 4 B). The ability of the droncEcRBE to
bind EcR–Usp was determined by EMSA, and as shown in
Fig. 4 C, EcR–Usp formed a specific complex that was abol-
ished when competed with the hspEcRBE oligonucleotide.
Mutation of the droncEcRBE rendered it incapable of bind-
ing EcR–Usp (Fig. 4 C).
The EcR-B1 isoform specifically binds to the 
dronc promoter
In Drosophila, the EcR-B1 isoform is predominantly expressed
in tissues that are destined to undergo PCD, whereas the EcR-A
isoform is predominant in tissues which undergo morpho-
genesis and form adult structures (Talbot et al., 1993). Based
on these observations, we predicted that dronc, which is ex-
pressed in tissues undergoing PCD, is likely to be regulated by
the EcR-B1 isoform. Therefore, we analyzed the expression of
EcR isoforms in l(2)mbn cells that also undergo PCD in re-
sponse to ecdysone. Using primers specific for each isoform in
RT-PCR analysis, we found that the EcR-B1 and EcR-B2 iso-
Figure 3. dronc upstream promoter harbors a putative EcRBE. 
(A) In vitro translated EcR and Usp proteins were incubated with the 
EcR consensus probe hspEcRBE for 20 min in the presence of dronc 
promoter fragments. 400 bp PCR fragments spanning the dronc 
promoter region from 2.8 to 1.1 kb were gel purified and 400 ng was 
used in each reaction. Positive control (hspEcRBE) was used at 40 ng 
(equimolar). Complexes were resolved on an acrylamide/TBE gel, 
dried on 3 MM Whatmann paper, and exposed to Kodak film over-
night. EcR–UsP complex is indicated. (B) EMSA experiment was 
performed as in A except PCR fragments used as competitors spanned 
the regions from 1.42 to 1.0 kb. hspEcRBE was used as the probe. 
(C) EMSA was performed as in A. Negative control competitor (D4) 
corresponds to the dronc promoter region between 67 to 7 bp upstream 
of the transcription start site. Oligonucleotide competitors correspond 
to the dronc promoter region 1.44 to 1.2 kb upstream of the tran-
scription start site. HspEcRBE was used as the probe.
Figure 4. droncEcRBE binds EcR–Usp. (A) The EcR consensus 
binding site, its variations, and the putative droncEcRBE sequences 
are shown. The conserved residues in the droncEcRBE are under-
lined. The asterisks represent the residues that have been mutated 
in a mutant droncEcRBE, which was used in the following studies. 
These sequences correspond to the oligonucleotides used in EMSA. 
(B) In vitro translated EcR and Usp proteins were incubated with the 
EcR consensus probe (hspEcRBE) for 20 min in the presence of 
increasing amounts of hspEcRBE competitor, droncEcRBE competitor, 
or droncEcRBE mutant competitor oligonucleotides. Complexes 
were resolved on an acrylamide/TBE gel, dried on 3 MM Whatmann 
paper, and exposed to Kodak film overnight. EcR–UsP complex is 
indicated. (C) EMSA was performed as in B. Probes used were the 
droncEcRBE and droncEcRBE mutant oligonucleotides.dronc expression is regulated by EcR–Usp | Cakouros et al. 635
forms were highly abundant in l(2)mbn cells, whereas EcR-A
was not detectable (Fig. 5 A). In cDNA prepared from total
larvae, EcR-A was clearly evident. To determine which iso-
form is recruited to the dronc promoter, EMSA analysis was
performed using isoform-specific EcR antibodies. Nuclear ex-
tracts from l(2)mbn cells revealed a single complex binding to
the droncEcRBE probe, which was entirely supershifted by an
EcR antibody that recognizes all EcR isoforms (Fig. 5 B). The
EcR-B1 isoform antibody also supershifted the complex,
whereas the EcR-A isoform-specific antibody had no effect. As
expected, the hspEcRBE oligonucleotide competed most of
the complex. Mutation of the droncEcRBE completely inhib-
ited binding of the EcR–Usp complex, and competitor oligo-
nucleotide or EcR common antibody had no effect as no com-
plex bound to this probe (Fig. 5 B). These results clearly
demonstrate that l(2)mbn cells express EcR-B1, and this iso-
form is specifically recruited to the dronc promoter. As specific
EcR-B2 antibodies are unavailable, we were unable to test if
this isoform also binds to the droncEcRBE. However, as EcR-
B1 specific antibody supershifts most of the complex, it is ap-
parent that most of the binding in the l(2)mbn nuclear ex-
tracts is due to the EcR-B1 isoform.
EcR-B1 is predominantly expressed in salivary glands and 
midgut and binds to the dronc promoter in these tissues
Because dronc is predominantly expressed in midgut and
salivary glands from early (2 h after puparium formation in
the midgut) and late prepupae (12 h after puparium for-
mation in salivary glands), these tissues were analyzed for
EcR expression. RT-PCR analysis showed the expression
of EcR-B1 but not EcR-B2 or EcR-A in both salivary
glands and midgut (Fig. 6 A). Increasing the number of
PCR cycles did also reveal the presence of EcR-B2 (unpub-
lished data). Nuclear extracts prepared from staged animals
revealed binding of the EcR–Usp to the droncEcRBE
probe from early to late prepupae, which correlates with
the stages of midgut and salivary gland cell death (Fig. 6
B). Binding of the EcR complex was abolished upon muta-
tion of the droncEcRBE (Fig. 6 B). Antibody supershift ex-
periments using nuclear extracts from total larvae at the
mid prepupal stage showed the binding of EcR-B1 isoform
to the EcRBE (Fig. 6 C). Interestingly, EcR-A isoform was
also capable of binding to the EcRBE, but given its lack of
expression in salivary gland and midgut, this is likely due
to the contribution of other larval tissues in the extracts
prepared from whole prepupae (Fig. 6 C). When analyzing
nuclear extracts from specific tissues, it was evident that
EcR-B1 in prepupal salivary gland (12 h) and midgut (2 h)
binds to the dronc promoter, however no supershift was
seen with the EcR-A antibody (Fig. 6 D). Cold EcRBE
(droncEcRBE) competitor eliminated binding of the EcR–
Usp complex as expected. These results clearly demonstrate
that EcR-B1 predominantly binds the dronc promoter at
least in these two tissues.
droncEcRBE is important for ecdysone-mediated 
dronc transcription
Having established the binding of EcR–Usp to the dronc
promoter, we determined the significance of direct EcR–
Usp binding in ecdysone-mediated dronc transcription of
this caspase. To assess this, the dronc promoter-luciferase
reporter constructs with or without EcRBE mutations were
introduced into l(2)mbn cells, and ecdysone-mediated re-
porter expression was analyzed. The wild-type promoter
was up-regulated in response to ecdysone treatment, and
cotransfection of EcR-B1 isoform enhanced ecdysone-
mediated transcription (Fig. 7 A). However, mutation of
the EcR binding site in the promoter abolished reporter ex-
pression in response to ecdysone treatment, and cotransfec-
tion of increasing amounts of EcR-B1 had no enhancing
effect (Fig. 7 A). Because the region between 2.8–1.1 kb of
the promoter is sensitive to TSA treatment (Fig. 1 B), we
wished to determine if the EcR mutation inhibits the ef-
fects of TSA to determine if the response to TSA is due to
the EcRBE or another region of the upstream promoter.
The wild-type dronc promoter-reporter was activated by
TSA treatment, whereas the EcR mutation significantly in-
hibited this activation (Fig. 7 B). These results demon-
strate that the EcR binding site possibly recruits a histone
deacetylase for repression of transcription in the absence of
ecdysone and is important for ecdysone-mediated dronc
transcription.
Figure 5. l(2)mbn cells express the EcR-B1 isoform, which binds 
to the dronc promoter. (A) 10
7 l(2)mbn cells were treated with 10  M 
ecdysone for the indicated time. RNA was extracted from cells and 
analyzed by RT-PCR to detect specific EcR isoforms. The last lane 
of the gel shows EcR isoforms expressed in late third instar larvae/
prepupae (120 h after egg laying). (B) 9  g of nuclear extracts prepared 
from l(2)mbn cells treated with ecdysone for 6 h was incubated 
with the droncEcRBE or the EcRBE mutant probe for 20 min in the 
presence of 2  l of EcR common, EcR-B1, or EcR-A antibody. A 
mouse control antibody was also used. Complexes were resolved 
on an acrylamide/TBE gel, dried on 3 MM Whatmann paper, and 
exposed to Kodak film overnight. EcR–Usp complex (EcR) and 
supershifted EcR–Usp complex (ss) are indicated.636 The Journal of Cell Biology | Volume 165, Number 5, 2004
droncEcRBE is important for dronc expression in 
specific tissues
We have recently reported that the 2.8-kb dronc promoter
region contains most necessary elements required for correct
spatial and temporal expression (Daish et al., 2003). Inter-
estingly, we also found that the deletion of the 2.8-kb pro-
moter down to 1.1 kb abolished expression in larval/prepu-
pal salivary glands and brain lobes, but not in midgut,
suggesting that an element located between 2.8 and 1.1 kb
promoter region is necessary for tissue-specific regulation of
dronc (Daish et al., 2003). One possibility is that the EcRBE
described in this work is responsible for this regulation of
dronc. To test this possibility, we created additional pro-
moter deletions and generated transgenic flies carrying the
dronc promoter driving expression of the LacZ gene. A trans-
genic construct containing the 1.64-kb dronc promoter and
including the droncEcRBE was able to drive reporter LacZ
gene expression in salivary glands, midgut (Fig. 8 A), and
brain lobes (not depicted) as assessed by the  -galactoside
activity staining of dissected tissues. It should be noted that
some premature  -galactoside activity was seen in salivary
glands of the 1.64-kb dronc promoter-LacZ transgenic flies
(unpublished data). This finding could imply that the 1.64-
kb promoter lacks some control elements that govern precise
timing of expression. A 1.33-kb promoter construct that de-
letes the region just past the EcRBE was unable to drive
LacZ gene expression in salivary glands (Fig. 8 A) and brain
lobes (not depicted). As expected, 1.33 kb of the promoter
could efficiently drive reporter expression in the midgut
(Fig. 8 A). These data suggested that the region between
1.64 and 1.33 kb, which harbors the EcRBE, is required for
dronc expression in specific tissues.
The role of direct EcR–Usp–mediated dronc regulation
was analyzed further in transgenic flies carrying mutations in
the droncEcRBE (Fig. 4 A) that abrogate EcR–Usp binding.
Transgenic flies carrying mutant EcRBE (in the 2.8 kb dronc
promoter  LacZ transgene) were carefully staged together
with transgenic flies carrying the wild-type 2.8-kb dronc pro-
moter-reporter, and Northern blot analysis was performed
comparing LacZ and endogenous dronc expression. In lines
where LacZ expression was driven by the wild-type dronc
promoter, LacZ and endogenous dronc show low to unde-
tectable levels of expression in midgut and salivary gland at
 12 and 10 h (relative to puparium formation), respec-
tively. Both LacZ and endogenous dronc transcription was
up-regulated in the midgut and salivary gland at 2 and 12 h,
respectively (Fig. 8 B), at a time when PCD occurs in these
tissues. Mutation of the EcRBE did not significantly affect
LacZ expression in midgut, whereas expression in salivary
gland was compromised at 12 h (Fig. 8 B) but detected at
later stages (not depicted). As expected, endogenous dronc
was transcriptionally up-regulated in both tissues (Fig. 8 B).
Figure 6. Salivary glands and midgut express EcR-B1, which binds 
to dronc promoter. (A) Salivary glands and midgut were dissected 
from animals at  24, 2, or 12 h relative to puparium formation. 
RNA was analyzed by RT-PCR to detect EcR isoform expression. 
Rp49 was used as a control. (B) 9  g of nuclear extracts prepared 
from various staged animals were incubated with the droncEcRBE 
or the EcRBE mutant probe for 20 min. Complexes were analyzed as 
in Figs. 4 and 5. EcR–Usp complex and supershift (ss) are indicated. 
Developmental stages are shown as hours relative to puparium 
formation. These stages represent early (0–4 h), mid (5–6 h), and 
late (9–11 h) prepupae and early (11–12 h) pupae. (C) EMSA was 
performed as in B in the presence of droncEcRBE cold competitor, 
2  l of EcR common antibody, EcR-B1, or EcR-A. EcR–Usp (EcR) 
and supershifted EcR–Usp (ss) complexes are indicated. (D) EMSA 
was performed as in C with 6  g on nuclear extract from salivary 
glands or midguts from 12 h (salivary gland) and 2 h (midgut) staged 
prepupae. EcR–Usp and supershifted (ss) complexes are shown. 40 
ng of cold competitor (droncEcRBE) was also added where indicated.dronc expression is regulated by EcR–Usp | Cakouros et al. 637
These results demonstrate that the droncEcRBE is required
for proper timing of dronc expression in the salivary gland.
Discussion
One of the major questions associated with the biological
actions of nuclear hormones is how a single hormone can
control differentiation, PCD, and proliferation in different
tissues. Although useful information has been obtained
from mammalian systems, problems of redundancy, differ-
ent nuclear receptor isoforms, and developmental defects
has hampered the ability to decipher the precise mecha-
nisms of nuclear receptor actions. Drosophila provides an
excellent system to address some fundamental questions as-
sociated with nuclear hormone actions. The steroid hor-
mone ecdysone specifically mediates the removal of larval
tissues, such as salivary glands and midgut at specific times
during development that are then replaced by adult tissues
from differentiating progenitor cells (Jiang et al., 1997;
Baehrecke, 2000, 2002). We have previously discovered
that ecdysone transcriptionally up-regulates dronc expres-
sion in salivary glands and midgut before PCD in these
tissues (Dorstyn et al., 1999a; Daish et al., 2003). The un-
derstanding of ecdysone-mediated spatial and temporal reg-
ulation of dronc expression will greatly assist in deciphering
Figure 7. Mutation of droncEcRBE reduces tran-
scription. (A) 2.5   10
6 l(2)mbn cells were transfected 
in triplicate with 2  g of dronc luciferase reporter, 
under the control of the 2.8-kb dronc promoter (Wt) or 
the promoter with the EcRBE mutated (EcRBE mutant). 
Where indicated, cells were also cotransfected with 1 
or 5  g of the EcR-B1 expression vector. After 24 h, 
cells were treated with 10  M ecdysone for 24 h where 
indicated ( ). Cell extracts were prepared and 100  g 
of protein assayed in triplicate for luciferase activity. 
Luciferase activity was subtracted from values obtained 
from empty luciferase vector transfections alone. 
(B) Transfections were performed as in A except 
trichostatin A (TSA) was added at 1  M as indicated. 
Error bars represent SD.
Figure 8. A region of the dronc promoter is required for spatial 
regulation of expression.  -Galactoside staining of midguts and salivary 
glands from dronc promoter-reporter transgenic Drosophila is shown. 
Tissues were dissected out at indicated developmental stages and 
stained with X-gal. (A, top) Qualitatively similar staining patterns for 
1.64 kb and 1.33 kb transgenes with expression throughout midgut 
and gastric cecae from late third instar larvae (3L) and early prepupae 
(PP). (bottom) Tissue-specific expression between 1.64 and 1.33 kb 
transgenes in salivary glands from early pupae demonstrating a 
requirement for the EcRBE for salivary gland-specific expression. 
Images are representative of multiple lines analyzed. Slight adjust-
ments of brightness and contrast were applied to all images to 
enhance quality of the presentation. However, this did not obscure 
or eliminate any information. These images were originally in color. 
(B) RNA was collected from staged animals carrying the wild-type 
dronc 2.8 kb promoter-LacZ transgene (WT) or EcRBE mutant 2.8 kb 
dronc promoter-LacZ transgene (Mut) at various times (in hours) 
relative to puparium formation from midguts ( 12 and 2 h) and 
salivary glands (10 and 12 h) and subjected to Northern blot analysis. 
Filters were probed with LacZ and dronc. Slight adjustments of 
brightness and contrast were applied to images to enhance quality 
of the presentation. (bottom) A picture of the gel before blotting to 
demonstrate that approximately equal amounts of intact RNA were 
present in all lanes. White lines indicate that intervening lanes have 
been spliced out.638 The Journal of Cell Biology | Volume 165, Number 5, 2004
how nuclear hormones control PCD of specific tissues at
precise stages of development.
With the use of luciferase reporter constructs and an
ecdysone responsive cell line in this paper, we have estab-
lished that the promoter region spanning 2.8 to 1.1 kb con-
tains important elements for ecdysone-mediated transcrip-
tion. We have further shown that this region harbors a
putative repressor that acts by recruiting a histone deacety-
lase as TSA treatment alleviates the repression of transcrip-
tion. However, TSA has no effect on the 1.1-kb promoter,
implying a histone deacetylase is recruited specifically to the
2.8–1.1 kb region. It was further shown that an EcR binding
site was present at 1.36 kb from the transcription start site
that specifically binds the EcR-B1 isoform in l(2)mbn cells
and Drosophila prepupal salivary gland/midgut nuclear ex-
tracts. Functional experiments in l(2)mbn cells have es-
tablished that this site is vital for dronc transcription as
mutation reduces ecdysone-mediated activation and transac-
tivation by EcR-B1. Due to the anomalies associated with
cell lines, the importance of the EcRBE was also assessed in
transgenic flies. The results are supported by our recent find-
ings that the 2.8-kb promoter contains all necessary ele-
ments for correct spatial regulation in Drosophila and delet-
ing the promoter to 1.1 kb (eliminating the EcR binding
site) renders it inactive in salivary glands and brain lobes
(Daish et al., 2003). This finding was further supported by
two in vivo approaches. First, the importance of dronc-
EcRBE was demonstrated by deletion just before the EcR
binding site, which had no abrogating effect on expression,
whereas deletion of the EcR binding site eliminated tran-
scription in both salivary glands and brain lobe without any
effect in the midgut. In addition, specific mutation of the
EcRBE delayed expression in salivary glands without affect-
ing midgut expression.
The lack of effect of EcRBE mutation in the midgut can
be explained in many ways. For example, a different chro-
matin structure along the dronc promoter in this tissue may
allow other factors to play a dominant role for dronc expres-
sion. The chromatin structure surrounding the EcR binding
site in the midgut may also preclude EcR–Usp from binding
to EcRBE (chromatin effects are not taken into consider-
ation in EMSA experiments). Coactivators play a key role in
modifying chromatin in nuclear hormone-mediated tran-
scription. For example, CARMER, a Drosophila histone
methyl transferase, required for ecdysone-induced expres-
sion of cell death genes in l(2)mbn cells (Cakouros et al.,
2004), may have some role in tissue-specific gene expression.
Alternatively, a midgut-specific transcription factor may in-
hibit binding of EcR–Usp to the dronc promoter. Our re-
sults show that the droncEcRBE has a lower affinity for the
EcR–Usp than the consensus site (Fig. 4 B), and expression
analysis shows a decrease in EcR-B1 expression at the time
of dronc expression in the midgut but an increase in expres-
sion in the salivary gland (Fig. 6 A). The lower affinity and
lower EcR expression suggests that insufficient amounts of
EcR bind to the promoter in the midgut, whereas the in-
crease in EcR-B1 expression in salivary glands overcome this
problem. In fact, this result is observed in EMSA performed
with extracts from tissues (Fig. 6 D) as identical levels of nu-
clear extracts show better binding from salivary gland ex-
tracts when compared with midgut. In any case, our results
show that the EcRBE is important for expression of dronc
specifically in salivary gland and brain lobes, but not in mid-
gut (Fig. 9).
Although the EcRBE is important for proper salivary gland
dronc transcription, it is possible that it does not function
alone but in cooperation with other factors that might govern
tissue-specific expression. Numerous examples of this already
exist such as the dGATAb transcription factor which binds
to three binding sites flanking a EcR–Usp binding site of
the Fbp1 promoter directing fat body-specific transcription
(Brodu et al., 1999). Studies on Sgs4 gene transcription,
which is specifically expressed in larval salivary glands, have
revealed that its tissue-specific expression is governed by the
Forkhead transcription factor in this tissue (Lehmann and
Korge, 1996). In light of this, we have previously shown that
BR-C binding sites exist in the dronc promoter (Cakouros et
al., 2002), and given their similarity to Forkhead binding
sites, it is possible that in salivary glands these sites also bind
Forkhead. However, this possibility remains to be tested.
Our data show that both EcR-B1 and EcR-A isoforms are
able to bind the dronc promoter EcRBE. Because EcR-A iso-
form is not expressed in l(2)mbn cells or larval/pupal midgut
and salivary glands (or expressed at levels below detection), it
is unlikely to play an important role in ecdysone-mediated
dronc transcription and PCD. Consistent with this, previous
works have shown that ectopic expression of the EcR-A iso-
form in EcR-B1–deficient salivary glands does not restore
their ability to respond to ecdysone (Bender et al., 1997).
In mammals it is well documented that nuclear receptors
recruit corepressors in the absence of ligand and specific co-
Figure 9. A model of ecdysone-mediated regulation of dronc 
expression. Ecdysone binds its heterodimeric receptor EcR–Usp and 
activates dronc expression in specific tissues by directly interacting 
with an EcRBE in the promoter. Recruitment of a potential repressor 
to EcRBE region is likely to be required for the correct temporal regu-
lation of dronc expression. EcR–Usp also regulates dronc transcription 
via ecdysone-induced transcription factors BR-C and E93, which may 
regulate temporal expression. Because E93 is required for expression 
of dronc in both larval salivary gland and midgut (Lee et al., 2000), 
it may also play a role in the spatial regulation of dronc expression.dronc expression is regulated by EcR–Usp | Cakouros et al. 639
activators in the presence of ligands (Shibata et al., 1997).
These coactivators can be tissue and promoter specific, and
bind to selected receptor isoforms. In this work, we have
provided evidence of the possible recruitment of a repressor
to the upstream dronc promoter region. This repressor seems
to recruit a histone deacetylase as assessed by sensitivity to
TSA. However, TSA sensitivity is reduced when the EcRBE
is mutated, indicating that the EcR–Usp binding is partly
responsible for recruiting this repressor. If a repressor was re-
cruited by EcR–Usp, then the mutation of EcRBE site
should show increased basal expression. However, this in-
crease was not observed. One possible reason for this lack of
increased activity is because increased promoter activity is
likely to be seen when the corepressor is inactivated or elimi-
nated, enabling coactivators to bind to the EcR–Usp, in-
creasing basal activity. However, in the absence of EcR bind-
ing to the promoter, coactivators are unable to be recruited
to the promoter, and there will therefore be no increase in
basal activity. Given that these results are suggestive of the
actions of a corepressor, more detailed experiments are being
undertaken to identify the recruitment of such a repressor.
Overall, we have demonstrated that the EcR-B1 isoform is
directly recruited to the dronc promoter and is required for
proper temporal dronc transcription in specific tissues. The
data presented here forms the foundation of future work to
address important questions associated with spatio-temporal
gene expression and PCD and the role of nuclear hormones
in these processes. We believe that the dronc promoter pro-
vides an important tool for such studies.
Materials and methods
Cell culture
l(2)mbn cells (a gift from A. Dorn, Johannes Gutenberg University, Mainz,
Germany; Ress et al., 2000) were grown in Schneider’s medium supple-
mented with 10% FBS. 2.5   10
6 per well cells were seeded in 6-well
plates in triplicate. Where necessary, 10  M ecdysone (Sigma-Aldrich)
was added for the desired time. Cycloheximide was used at 10  g/ml. TSA
(Sigma-Aldrich) was used at 1  M. Cell viability was assessed by trypan
blue exclusion.
Northern blotting and RT-PCR
Total RNA was extracted using Trizol reagent (Life Technologies), and 15–
20  g was analyzed by Northern blotting using 
32P-labeled probes as de-
scribed previously (Colussi et al., 2000; Cakouros et al., 2002). For RT-
PCR, 2  g RNA was used to generate cDNA using Superscript II reverse
transcriptase (Invitrogen). cDNA was diluted 1:10 and 1  l was used in a
standard PCR reaction. PCR conditions have been described previously
(Daish et al., 2003).
Immunoblotting
Cell lysates were electrophoresed on a 10% SDS PAGE, transferred onto
PVDF membrane (Schleicher & Schuell), and blocked for 4 h in 5% skim
milk. Affinity-purified DRONC antibody (Quinn et al., 2000; Dorstyn et
al., 2002) was used at a 1:300 dilution. Purified antibodies to EcR com-
mon, EcR-B1, and EcR-A from the hybridoma bank were used at a 1:2,000
dilution. Secondary HRP-conjugated anti–mouse antibody (Amersham
Biosciences) was used at a 1:2,000 dilution. Signals were detected using
the ECL system (Amersham Biosciences).
Expression constructs
The luciferase reporter pxpGDR2.8kbLuc (generated by P. Colussi, Han-
son Institute, Adelaide, Australia) contains a 2.8-kb region of the dronc
promoter upstream of the transcription start site up to the ATG cloned into
the luciferase reporter vector pxpG (provided by P. Cockerill, Hanson In-
stitute, Adelaide, Australia). Deletions of the promoter were made by PCR
amplification from 1.1 kb and 0.54 kb relative to transcription start site up
to the ATG site and cloned into the pxpG luciferase reporter vector. EcR-
B1 expression construct was provided by M. Bender (University of Geor-
gia, Athens, GA).
Preparation of nuclear extracts and EMSA
7.5   10
6 l(2)mbn cells were pelleted, washed once in PBS, resuspended
in 800  l of buffer A (10 mM Hepes, pH 7.6, 10 mM KCl, 1.5 mM MgCl2,
0.1 mM EDTA, 0.1 mM EGTA, and Complete™ protease inhibitors from
Roche), and placed on ice for 15 min. 0.1% NP-40 was added, and cell
suspension was vortexed for 30 s and centrifuged at 13 K for 30 s at 4 C.
Nuclear pellets were resuspended in 80  l of buffer C (10 mM Hepes, pH
7.6, 400 mM NaCl, 7.5 mM MgCl2, 0.2 mM EDTA, 0.1 mM EGTA, 1 mM
DTT, 0.5 mM PMSF, and Complete™) and incubated on ice for 40 min
while shaking. Extracts were centrifuged for 5 min at 13 K, and supernatant
were aliquoted and frozen at  70 C. Nuclear extracts were prepared from
staged larvae ranging from 120–132 h AEL by homogenizing 50 larvae in
300  l of buffer A and removed to a fresh tube in a total of 600  l devoid
of larval debri. After incubation on ice for 15 min, 10  l of 10% NP-40
was added, lysates were vortexed for 30 s, and spun at 13 K for 30 s. Nu-
clear pellets were resuspended in 60–100  l of buffer C and incubated on
ice with shaking for 1 h. Lysates were centrifuged for 5 min at 13 K at 4 C
and supernatant frozen as aforementioned. EMSA was performed by incu-
bating 7–12  g (4  l) of nuclear extracts in binding buffer (20 mM Hepes,
pH 7.9, 80 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT, 0.5 mM
PMSF, and 10% glycerol) containing 1mg/ml BSA and 1  g of poly dI/dC
for 5 min on ice. Where needed, 2  l of murine EcR-B1, EcR common,
EcR-A antibody, or a control antibody was also added to the nuclear ex-
tracts and incubated on ice before the addition of labeled probe. Where
indicated, 40 ng of cold competitor oligonucleotide was also included. 0.2
ng of labeled probe was added and incubated on ice for a further 20 min.
5  l of 5  loading buffer was added, and samples were electrophoresed
on a 5% polyacrylamide/0.5 TBE gel. The gel was dried down onto 3 MM
Whatmann paper and exposed to Kodak X-ray film.
Transfection and luciferase assay
2  g of pxpGDR2.8kbLuc, pxpGDR2.8kbEcRmutLuc, pxpGDR1.1kbLuc,
or pxpGDR0.54kbLuc was transfected using Cellfectin alone or with 1–5
 g of EcR-B1 expression constructs. Equal amounts of DNA were used
with the pIE1-4 expression vector. DNA in a total volume of 100  l in
Schneider media (without FBS) was added to Cellfectin (2:9 ratio) in 100
 l of total media devoid of FBS and incubated at RT for 15 min. 800  l of
serum-free medium was added and overlaid onto 2.5   10
6 cells in 6-well
plates. Cells were incubated with the DNA/Cellfectin mixture for 5 h. The
medium was replaced by 3 ml of Schneider media supplemented with
10% FBS, and cells were allowed to recover for 24 h. Where needed, 10
 M ecdysone was added for 24 h. Cells were harvested 48 h after transfec-
tion, resuspended in lysis buffer (100 mM phosphate buffer, pH 7.8, 10
 M EDTA, and 2 mM DTT), and frozen three times in liquid nitrogen. After
centrifugation for 5 min at 13 K, the supernatant was analyzed for lu-
ciferase activity. 60–100  g of protein was assayed in 200  l of assay
buffer (100 mM phosphate buffer, 8 mM MgSO4, 2 mM DTT, 0.75 mM
ATP, and 0.175 mM coenzyme A) using an illuminometer (Packard Instru-
ment Co.).
Generation and analysis of dronc reporter lacZ lines
1.64 kb and 1.33 kb of the dronc promoter were PCR amplified from Dro-
sophila genomic DNA using Expand High Fidelity PCR System (Roche)
with the primer sets DrPrF3cBglII (5  CCG AGA TCT ATG TAC GTT ATG
TTA TAG TAA GTG TA 3 ); DrPrR1BglII (5  CGG AGA TCT CCG GAT
ATG GCT TCC ACG CGT 3 ) and DrPrF3eBglII (5  CGA AGA TCT AAT
TGT GTA CAA CTA AAG GAA 3 ); DrPrR1BglII, respectively. PCR prod-
ucts were cloned into pGem-T easy (Promega), and then subcloned into
the BglII site of the p-element transformation lacZ reporter vector
pCaSpeR-NLSlacZ (provided by Carl Thummel, Howard Hughes Medical
Institute, University of Utah, Salt Lake City, UT) after BglII digestion. The
2.8-kb dronc-LacZ reporter construct has been described previously (Daish
et al., 2003). The EcRBE mutations were introduced by PCR using standard
techniques. Clones were sequenced for correct orientation, and transgenic
flies were generated and transgenes mapped by established techniques.
Animals were staged and tissues stained for  -galactosidase activity as de-
scribed previously (Daish et al., 2003). In brief, third instar larval stages
were determined by the gut clearance technique after growth of animals
on bromophenol blue–supplemented food. Prepupal and pupal stages
were attained by collecting newly pupariated animals from clear gutted
third instar larvae populations every 30 min and ageing at 25 C to desired
stages before collection and analysis. Images were acquired using a micro-640 The Journal of Cell Biology | Volume 165, Number 5, 2004
scope (model SZ40; Olympus) set at 3–4  objective with a 2  adaptor
lens (110AL2x), fitted with a digital camera (model DP11; Olympus). Im-
ages were cropped and processed using Adobe Photoshop software.
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